- Regular updates
- No spam
Innogenetics' managing director said: "Innogenetics had recently narrowed its focus and was profitable in 2009. Our first half-year results were outstanding. And our new owner's activities and ours are highly complementary."
Innogenetics is one of Flanders' pioneers in the biotech industry. The firm specializes in the development and marketing of diagnostic assays in the fields of Infectious Diseases, Genetic Testing, Transplantation, Neurodegeneration and Oncology, with a special focus on molecular diagnostics and multiparameter testing. (Reported by De Tijd and De Standaard newspaper)